Resources by Therapeutic Area
Evaluation Of Th2 And Th17 Cytokine Levels In Serum From Asthmatics Using The High Sensitivity Quanterix Simoa HD-1 Platform
American Thoracic Society | May 15, 2016
This study investigated the capability of the Quanterix Simoa HD-1 to measure interleukin (IL)-5 , - 13, and -17A in serum samples to determine if increasing assay sensitivity will allow us to convincingly detect these cytokines at baseline.
Development of an ultra-sensitive Simoa assay to enable GDF11 detection: a comparison across bioanalytical platforms
Bioanalysis | February 26, 2016
Four bioanalytical platforms were evaluated to optimize sensitivity and enable detection of recombinant human GDF11 in biological matrices. Simoa achieved the greatest sensitivity, an improvement of 100-fold over the next sensitive platform.
January 25-26, 2016
San Diego, CA USA January 25-26, 2016 Registration at www.gtcbio.com
Immunochemistry for high-throughput screening of human exhaled breath condensate (EBC) media: implementation of automated Quanterix SIMOA instrumentation
Journal of Breath Research| December 11, 2015
Immunochemistry is an important clinical tool for indicating biological pathways leading towards disease. Standard enzyme-linked immunosorbent assays (ELISA) are labor intensive and lack sensitivity at low-level concentrations. Here we report on emerging technology implementing fully automated ELIS…